Teva Says Wyeth Patent Deal Doesn't Step On Antitrust Law
Teva Pharmaceuticals USA Inc. on Friday moved to toss direct purchasers' claims in multiple class actions and individual suits accusing it of conspiring with Wyeth LLC to delay a generic antidepressant's...To view the full article, register now.
Already a subscriber? Click here to view full article